The Company, based on its current plans and initiatives, expects full-year 2024 revenue guidance range of $114M-118M and projects operating cash flow breakeven by year-end.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AKYA:
- Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
- Akoya Biosciences Inc (AKYA) Q4 Earnings Cheat Sheet
- Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
- Akoya Biosciences’ PhenoCycler-Fusion platform used by QSBC
- Akoya Biosciences announces establishment of Scientific Advisory Board
